Why do men skip their cancer pills? french study investigates
NCT ID NCT07451002
Summary
This study aims to understand how well men with advanced prostate cancer stick to their prescribed medication, apalutamide, in real-world settings. It will follow 270 patients in France for one year, using questionnaires to track their adherence and identify factors that make it easier or harder to take the drug consistently. The goal is to gather knowledge to help future patients stay on treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATIC NEOPLASMS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Centre Francois Baclesse
RECRUITINGCaen, 14076, France
Conditions
Explore the condition pages connected to this study.